Blanchette, Phillip S. http://orcid.org/0000-0001-8865-0996
Lam, Melody
Richard, Lucie
Allen, Britney
Shariff, Salimah Z.
Vandenberg, Ted
Pritchard, Kathleen I.
Chan, Kelvin K. W.
Louie, Alexander V.
Desautels, Danielle
Raphael, Jacques
Earle, Craig C.
Funding for this research was provided by:
Academic Medical Organization of Southwestern Ontario (S17-001)
Ministry of Health and Long-Term Care, Ontario
Article History
Received: 12 August 2019
Accepted: 30 August 2019
First Online: 1 October 2019
Compliance with ethical standards
:
: KIP has consulted for Pfizer, Roche, Amgen, Novartis, Eisai, Genomic Health, and Myriad Genetics Laboratories. TV has consulted for Novartis and Roche. AL has consulted for AstraZeneca and received honoraria from Varian Medical Systems Inc. JR has received honoraria from F. Hoffmann-La Roche. All other authors report no conflicts.
: This article does not contain any studies with human participants or animals performed by any of the authors. The use of data in this project was authorized under Section 45 of Ontario’s Personal Health Information Protection Act, which does not require review by a research ethics board.
: ICES is a prescribed entity under Section 45 of Ontario’s Personal Health Information Protection Act. Section 45 authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to, or planning for all or part of the health system. This project was conducted under Section 45, and approved by ICES’ Privacy and Compliance Office.